ArticleTherapeutic innovation & regulatory science2024

US FDA's Dose Optimization Postmarketing Requirements and Commitments of Oncology Approvals and the Impact on Product Labels from 2010 to 2022: An Emerging Landscape from Traditional to Novel Therapies.

Joseph M Gendy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.